Beit Jala Pharmaceutical Company (PEX:BJP)

Market Cap	25.34M
Revenue (ttm)	12.34M +15.7%
Net Income	2.23M -3.2%
EPS	0.32 -3.3%
Shares Out	7.00M
PE Ratio	11.39
Forward PE	n/a
Dividend	0.12 (3.31%)
Ex-Dividend Date	May 3, 2026

Volume	132,383
Open	3.620
Previous Close	3.600
Day's Range	3.620 - 3.620
52-Week Range	2.750 - 3.620
Beta	-0.01
Analysts	n/a
Price Target	n/a
Earnings Date	May 25, 2026

About PEX:BJP

Beit Jala Pharmaceutical Company engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority. It provides its products in various forms, such as tablets, capsules, powders, oral drops, solutions, suspensions, syrups, sprays, creams, gels, lotions, ampoules, and suppositories. The company also offers medicated shampoos; and sterile products, including eye, ear, and nose drops, as well as ear and nose ointments. In addition, it exports its products to the Middle East and North Africa region, Europe, Central Africa,...

• Industry: Pharmaceutical Preparations
• Founded: 1933
• Employees: 220
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: BJP

Financial Performance

In 2025, PEX:BJP's revenue was 12.78 million, an increase of 32.28% compared to the previous year's 9.66 million. Earnings were 2.73 million, an increase of 55.69%.